Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 2000 Dec;46:2430-4, 2437-40.

Interstitial cystitis. Etiology, diagnosis, and treatment.

J C Nickel 1
PMCID: PMC2144998  PMID: 11153410

Abstract

OBJECTIVE: To review current knowledge about the epidemiology, etiology, diagnosis, and treatment of interstitial cystitis, with special emphasis on management of this condition by family physicians. QUALITY OF EVIDENCE: Articles were identified through MEDLINE and review of abstracts presented at Urology and Interstitial Cystitis meetings during the last decade. Recent reviews were further searched for additional studies and trials. Data were summarized from large epidemiologic studies. Etiologic theories were extracted from current concepts and reviews of scientific studies. Diagnostic criteria described in this review are based on clinical interpretation of National Institutes of Health (NIH) research guidelines, interpretation of data from the NIH Interstitial Cystitis Cohort Study, and recent evidence on use of the potassium sensitivity test. Treatment suggestions are based on six randomized placebo-controlled clinical treatment trials and best available clinical data. MAIN MESSAGE: Interstitial cystitis affects about 0.01% to 0.5% of women. Its etiology is unknown, but might involve microbiologic, immunologic, mucosal, neurogenic, and other yet undefined agents. The diagnosis of interstitial cystitis is a diagnosis of exclusion. It is impossible to provide a purely evidence-based treatment strategy, but review of available evidence suggests that conservative supportive therapy (including diet modification); oral treatment with pentosan polysulfate, amitriptyline, or hydroxyzine; and intravesical treatments with heparinlike medications, dimethyl sulfoxide, or BCG vaccine could benefit some patients. CONCLUSION: Family physicians should have an understanding of interstitial cystitis and be able to make a diagnosis and formulate an evidence-based treatment strategy for their patients.

Full text

PDF
2430

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. B., Parivar F., Lee G., Wallington T. B., MacIver A. G., Bradbrook R. A., Gingell J. C. The enigma of interstitial cystitis--an autoimmune disease? Br J Urol. 1989 Jan;63(1):58–63. doi: 10.1111/j.1464-410x.1989.tb05124.x. [DOI] [PubMed] [Google Scholar]
  2. Bade J. J., Laseur M., Nieuwenburg A., van der Weele L. T., Mensink H. J. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol. 1997 Feb;79(2):168–171. doi: 10.1046/j.1464-410x.1997.03384.x. [DOI] [PubMed] [Google Scholar]
  3. Baskin L. S., Tanagho E. A. Pelvic pain without pelvic organs. J Urol. 1992 Mar;147(3):683–686. doi: 10.1016/s0022-5347(17)37348-2. [DOI] [PubMed] [Google Scholar]
  4. Chaiken D. C., Blaivas J. G., Blaivas S. T. Behavioral therapy for the treatment of refractory interstitial cystitis. J Urol. 1993 Jun;149(6):1445–1448. doi: 10.1016/s0022-5347(17)36411-x. [DOI] [PubMed] [Google Scholar]
  5. Chambers G. K., Fenster H. N., Cripps S., Jens M., Taylor D. An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis. J Urol. 1999 Sep;162(3 Pt 1):699–701. doi: 10.1097/00005392-199909010-00018. [DOI] [PubMed] [Google Scholar]
  6. Cornish J., Nickel J. C., Vanderwee M., Costerton J. W. Ultrastructural visualization of human bladder mucous. Urol Res. 1990;18(4):263–266. doi: 10.1007/BF00294770. [DOI] [PubMed] [Google Scholar]
  7. Curhan G. C., Speizer F. E., Hunter D. J., Curhan S. G., Stampfer M. J. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999 Feb;161(2):549–552. [PubMed] [Google Scholar]
  8. Elbadawi A. E., Light J. K. Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis. Urol Int. 1996;56(3):137–162. doi: 10.1159/000282832. [DOI] [PubMed] [Google Scholar]
  9. Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology. 1997 May;49(5A):14–40. doi: 10.1016/s0090-4295(99)80329-x. [DOI] [PubMed] [Google Scholar]
  10. Fleischmann J. D., Huntley H. N., Shingleton W. B., Wentworth D. B. Clinical and immunological response to nifedipine for the treatment of interstitial cystitis. J Urol. 1991 Nov;146(5):1235–1239. doi: 10.1016/s0022-5347(17)38056-4. [DOI] [PubMed] [Google Scholar]
  11. Gillenwater J. Y., Wein A. J. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol. 1988 Jul;140(1):203–206. doi: 10.1016/s0022-5347(17)41529-1. [DOI] [PubMed] [Google Scholar]
  12. Grabstald H., Chabon A., McSherry C. Prostate cancer: unusual metastases 20 years after 125iodine brachytherapy. J Urol. 1995 Jul;154(1):203–204. doi: 10.1016/s0022-5347(01)67268-9. [DOI] [PubMed] [Google Scholar]
  13. Haarala M., Jalava J., Laato M., Kiilholma P., Nurmi M., Alanen A. Absence of bacterial DNA in the bladder of patients with interstitial cystitis. J Urol. 1996 Nov;156(5):1843–1845. [PubMed] [Google Scholar]
  14. Hanno P. M. Amitriptyline in the treatment of interstitial cystitis. Urol Clin North Am. 1994 Feb;21(1):89–91. [PubMed] [Google Scholar]
  15. Hanno P. M. Analysis of long-term Elmiron therapy for interstitial cystitis. Urology. 1997 May;49(5A):93–99. doi: 10.1016/s0090-4295(97)00179-9. [DOI] [PubMed] [Google Scholar]
  16. Hanno P. M. Diagnosis of interstitial cystitis. Urol Clin North Am. 1994 Feb;21(1):63–66. [PubMed] [Google Scholar]
  17. Hanno P. M., Landis J. R., Matthews-Cook Y., Kusek J., Nyberg L., Jr The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol. 1999 Feb;161(2):553–557. doi: 10.1016/s0022-5347(01)61948-7. [DOI] [PubMed] [Google Scholar]
  18. Holm-Bentzen M., Jacobsen F., Nerstrøm B., Lose G., Kristensen J. K., Pedersen R. H., Krarup T., Feggetter J., Bates P., Barnard R. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol. 1987 Sep;138(3):503–507. doi: 10.1016/s0022-5347(17)43241-1. [DOI] [PubMed] [Google Scholar]
  19. Hwang P., Auclair B., Beechinor D., Diment M., Einarson T. R. Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis. Urology. 1997 Jul;50(1):39–43. doi: 10.1016/S0090-4295(97)00110-6. [DOI] [PubMed] [Google Scholar]
  20. Irwin P. P., Galloway N. T. Surgical management of interstitial cystitis. Urol Clin North Am. 1994 Feb;21(1):145–151. [PubMed] [Google Scholar]
  21. Jepsen J. V., Sall M., Rhodes P. R., Schmidt D., Messing E., Bruskewitz R. C. Long-term experience with pentosanpolysulfate in interstitial cystitis. Urology. 1998 Mar;51(3):381–387. doi: 10.1016/s0090-4295(97)00714-0. [DOI] [PubMed] [Google Scholar]
  22. Keay S., Zhang C. O., Baldwin B. R., Jacobs S. C., Warren J. W. Polymerase chain reaction amplification of bacterial 16S rRNA genes in interstitial cystitis and control patient bladder biopsies. J Urol. 1998 Jan;159(1):280–283. doi: 10.1016/s0022-5347(01)64082-5. [DOI] [PubMed] [Google Scholar]
  23. Korting G. E., Smith S. D., Wheeler M. A., Weiss R. M., Foster H. E., Jr A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis. J Urol. 1999 Feb;161(2):558–565. [PubMed] [Google Scholar]
  24. Messing E. M. The diagnosis of interstitial cystitis. Urology. 1987 Apr;29(4 Suppl):4–7. [PubMed] [Google Scholar]
  25. Morales A., Emerson L., Nickel J. C. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology. 1997 May;49(5A):111–113. doi: 10.1016/s0090-4295(97)00183-0. [DOI] [PubMed] [Google Scholar]
  26. Morales A., Emerson L., Nickel J. C., Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 1996 Jul;156(1):45–48. [PubMed] [Google Scholar]
  27. Morales A., Emerson L., Nickel J. C. Treatment of refractory interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(4):215–220. doi: 10.1007/BF01907075. [DOI] [PubMed] [Google Scholar]
  28. Moskowitz M. O., Byrne D. S., Callahan H. J., Parsons C. L., Valderrama E., Moldwin R. M. Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis. J Urol. 1994 Feb;151(2):343–345. doi: 10.1016/s0022-5347(17)34944-3. [DOI] [PubMed] [Google Scholar]
  29. Mulholland S. G., Hanno P., Parsons C. L., Sant G. R., Staskin D. R. Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology. 1990 Jun;35(6):552–558. doi: 10.1016/0090-4295(90)80116-5. [DOI] [PubMed] [Google Scholar]
  30. Nickel J. C., Cornish J. Ultrastructural study of an antibody-stabilized bladder surface: a new perspective on the elusive glycosaminoglycan layer. World J Urol. 1994;12(1):11–14. doi: 10.1007/BF00182045. [DOI] [PubMed] [Google Scholar]
  31. Nickel J. C., Downey J., Morales A., Emerson L., Clark J. Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier. J Urol. 1998 Aug;160(2):612–614. [PubMed] [Google Scholar]
  32. Nickel J. C., Emerson L., Cornish J. The bladder mucus (glycosaminoglycan) layer in interstitial cystitis. J Urol. 1993 Apr;149(4):716–718. doi: 10.1016/s0022-5347(17)36191-8. [DOI] [PubMed] [Google Scholar]
  33. Oravisto K. J. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn. 1975;64(2):75–77. [PubMed] [Google Scholar]
  34. Parsons C. L., Benson G., Childs S. J., Hanno P., Sant G. R., Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol. 1993 Sep;150(3):845–848. doi: 10.1016/s0022-5347(17)35629-x. [DOI] [PubMed] [Google Scholar]
  35. Parsons C. L. Bladder surface glycosaminoglycan: efficient mechanism of environmental adaptation. Urology. 1986 Feb;27(2 Suppl):9–14. [PubMed] [Google Scholar]
  36. Parsons C. L., Boychuk D., Jones S., Hurst R., Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol. 1990 Jan;143(1):139–142. doi: 10.1016/s0022-5347(17)39897-x. [DOI] [PubMed] [Google Scholar]
  37. Parsons C. L., Greenberger M., Gabal L., Bidair M., Barme G. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol. 1998 Jun;159(6):1862–1867. doi: 10.1016/S0022-5347(01)63178-1. [DOI] [PubMed] [Google Scholar]
  38. Parsons C. L., Koprowski P. F. Interstitial cystitis: successful management by increasing urinary voiding intervals. Urology. 1991 Mar;37(3):207–212. doi: 10.1016/0090-4295(91)80286-g. [DOI] [PubMed] [Google Scholar]
  39. Parsons C. L., Mulholland S. G. Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol. 1987 Sep;138(3):513–516. doi: 10.1016/s0022-5347(17)43243-5. [DOI] [PubMed] [Google Scholar]
  40. Perez-Marrero R., Emerson L. E., Feltis J. T. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988 Jul;140(1):36–39. doi: 10.1016/s0022-5347(17)41478-9. [DOI] [PubMed] [Google Scholar]
  41. Perez-Marrero R., Emerson L. E., Maharajh D. O., Juma S. Prolongation of response to DMSO by heparin maintenance. Urology. 1993 Jan;41(1 Suppl):64–66. doi: 10.1016/0090-4295(93)90198-j. [DOI] [PubMed] [Google Scholar]
  42. Peters K. M., Diokno A. C., Steinert B. W., Gonzalez J. A. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup. J Urol. 1998 May;159(5):1483–1487. doi: 10.1097/00005392-199805000-00019. [DOI] [PubMed] [Google Scholar]
  43. Peters K., Diokno A., Steinert B., Yuhico M., Mitchell B., Krohta S., Gillette B., Gonzalez J. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J Urol. 1997 Jun;157(6):2090–2094. [PubMed] [Google Scholar]
  44. Sant G. R. Intravesical 50% dimethyl sulfoxide (Rimso-50) in treatment of interstitial cystitis. Urology. 1987 Apr;29(4 Suppl):17–21. [PubMed] [Google Scholar]
  45. Seshadri P., Emerson L., Morales A. Cimetidine in the treatment of interstitial cystitis. Urology. 1994 Oct;44(4):614–616. doi: 10.1016/s0090-4295(94)80074-x. [DOI] [PubMed] [Google Scholar]
  46. Silk M. R. Bladder antibodies in interstitial cystitis. J Urol. 1970 Mar;103(3):307–309. doi: 10.1016/s0022-5347(17)61948-7. [DOI] [PubMed] [Google Scholar]
  47. Simon L. J., Landis J. R., Erickson D. R., Nyberg L. M. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology. 1997 May;49(5A):64–75. doi: 10.1016/s0090-4295(99)80334-3. [DOI] [PubMed] [Google Scholar]
  48. Smith S. D., Wheeler M. A., Foster H. E., Jr, Weiss R. M. Improvement in interstitial cystitis symptom scores during treatment with oral L-arginine. J Urol. 1997 Sep;158(3 Pt 1):703–708. doi: 10.1097/00005392-199709000-00005. [DOI] [PubMed] [Google Scholar]
  49. Teichman J. M., Nielsen-Omeis B. J. Potassium leak test predicts outcome in interstitial cystitis. J Urol. 1999 Jun;161(6):1791–1796. [PubMed] [Google Scholar]
  50. Theoharides T. C. Hydroxyzine in the treatment of interstitial cystitis. Urol Clin North Am. 1994 Feb;21(1):113–119. [PubMed] [Google Scholar]
  51. Waxman J. A., Sulak P. J., Kuehl T. J. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol. 1998 Nov;160(5):1663–1667. [PubMed] [Google Scholar]
  52. Whitmore K. E. Self-care regimens for patients with interstitial cystitis. Urol Clin North Am. 1994 Feb;21(1):121–130. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES